Marianna Borecka
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A deep intronic recurrent CHEK2 variant c.1009-118_1009-87delinsC affects pre-mRNA splicing and contributes to hereditary breast cancer predisposition.
Journal: Breast (Edinburgh, Scotland)
Published: February 21, 2024
A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer.
Journal: Cancer medicine
Published: February 15, 2024
Population-specific validation and comparison of the performance of 77- and 313-variant polygenic risk scores for breast cancer risk prediction.
Journal: Cancer
Published: January 25, 2024
Germline multigene panel testing of patients with endometrial cancer.
Journal: Oncology letters
Published: November 22, 2022
Novel presentation of the c.1856A > G (p.Asp619Gly) TSHR gene-activating variant: relapsing hyperthyroidism in three subsequent generations manifesting in early childhood and an in vitro functional study.
Journal: Hormones (Athens, Greece)
Published: February 23, 2021
Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer.
Journal: Cancers
Published: March 15, 2020
Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: August 15, 2019
Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: August 15, 2019
Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon.
Journal: Cell death & disease
Published: July 06, 2019
Last Updated: 09/26/2026